RESTAGING TRANSURETHRAL RESECTION OF HIGH RISK SUPERFICIAL BLADDER CANCER IMPROVES THE INITIAL RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY
Author:
Affiliation:
1. From the Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference16 articles.
1. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997
2. Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup;Davis;J Urol,2002
3. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression;Herr;J Urol,1989
4. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer;Solsona;J Urol,2000
5. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression;Holmäng;J Urol,2002
Cited by 158 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prospective evaluation of surgical margins in non-muscle invasive bladder cancer following primary transurethral resection;The French Journal of Urology;2024-09
2. Management of high-grade papillary Ta or T1 bladder cancer after restaging transurethral resection: A retrospective study comparing Bacillus Calmette–Guerin therapy upfront versus a third resection;Progrès en Urologie;2023-11
3. Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy;Molecular Oncology;2023-10-05
4. Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non‐muscle‐invasive bladder cancer: A retrospective multicenter study;International Journal of Urology;2023-09-04
5. Clinical and pathological predictors of persistent T1 HG at second resection;Urologia Journal;2023-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3